The percentage expression of CD36 on ASCs was lower in the presence of cardiovascular disease (30.0% versus 59.8%; p = 0.029), with a statistically significance level that would not survive adjustment of type I error inflation due to multiple testing. This evidence concerns the gene CD36 and cardiovascular disorder.